NCT05006807

Brief Summary

The overall objective of this research is to evaluate different laboratory-built and commercially available sensors used to measure the effects of neuromuscular blocking drugs on neuromuscular function during surgery, by measuring evoked thumb twitch response to ulnar nerve stimulation (also known as "twitch monitoring"). The specific aim is to compare mechanomyography, which is the "gold standard" laboratory measurement to assess neuromuscular blockade, to the sensors used in commercially available neuromuscular blockade monitors, such as acceleromyography and electromyography. The study endpoints are the train-of-four count (TOFC), the ratio of the height of the 4th twitch to the height of the 1st twitch (train-of-four ratio, TOFR), and the post tetanic count (PTC). The mechanomyography devices have been constructed in our laboratory and are not commercially available.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 16, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

July 8, 2026

Completed
Last Updated

July 8, 2026

Status Verified

December 1, 2024

Enrollment Period

2.8 years

First QC Date

August 10, 2021

Results QC Date

June 10, 2026

Last Update Submit

June 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Train-of-four Ratio

    Determine evoked thumb twitch response to ulnar nerve train-of-four stimulation then determine the ratio of the amplitude of the fourth twitch divided by the first twitch, referred to as the train-of-four ratio. The train-of-four ratio is expected to be 1.0 in the absence of neuromuscular blocking drugs. The range of possible train-of-four ratios is 0-1.6. Results that deviate from a train-of-four ratio of 1.0 represent inaccuracy of the measurement.

    Procedure (from the induction of anesthesia until emergence of anesthesia)

Study Arms (1)

Twitch Monitoring

Patients undergoing surgery with general anesthesia requiring neuromuscular blockade.

Device: Mechanomyograph Twitch MonitorDevice: Stimpod Twitch MonitorDevice: TetraGraph Twitch MonitorDevice: TwitchView Twitch MonitorDevice: Nihon Kohden Twitch MonitorOther: Palpation of twitch count

Interventions

Measurement of train-of-four count and ratio and post tetanic count

Twitch Monitoring

Measurement of train-of-four count and ratio and post tetanic count

Twitch Monitoring

Measurement of train-of-four count and ratio and post titanic count

Twitch Monitoring

Measurement of train-of-four count and ratio and post tetanic count

Twitch Monitoring

Measurement of train-of-four count and ratio and post tetanic count

Twitch Monitoring

The train-of-four count is determined by manual palpation of the evoked twitch response

Twitch Monitoring

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients 18 years of age or older undergoing anesthesia that requires neuromuscular blocking drugs at University of Washington Medical Center.

You may qualify if:

  • years of age or greater
  • Undergoing anesthesia that requires neuromuscular blocking drugs

You may not qualify if:

  • Less than 18 years of age
  • Undergoing anesthesia that does not require neuromuscular blocking drugs
  • Undergoing a procedure in which access to one or both arms is limited
  • Anatomical abnormalities of the hands or arms that preclude twitch monitoring with ulnar nerve stimulation and evoked thumb twitch response

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington Medical Center

Seattle, Washington, 98195, United States

Location

Related Publications (2)

  • Wedemeyer Z, Bowdle A, Jelacic S, Silliman W, Michaelsen KE. The effect of excessive noise rejection, noise filtering and twitch threshold on mechanomyograph twitch measurements. Anaesth Crit Care Pain Med. 2026 May;45(3):101780. doi: 10.1016/j.accpm.2026.101780. Epub 2026 Mar 3.

  • Wedemeyer Z, Jelacic S, Michaelsen K, Silliman W, Togashi K, Bowdle A. Comparative performance of stimpod electromyography with mechanomyography for quantitative neuromuscular blockade monitoring. J Clin Monit Comput. 2024 Feb;38(1):205-212. doi: 10.1007/s10877-023-01087-1. Epub 2023 Oct 13.

Limitations and Caveats

All data were collected in the absence of neuromuscular blocking drugs. This was also an important strength because it allowed the collection of a very large number of train-of-four ratio measurements when the true train-of-four ratio was know to be 1.0. an argument can be made that the performance of the monitors should be the best possible in the absence of neuromuscular blocking drugs since the signals produced by ulnar nerve stimulation are at the maximum.

Results Point of Contact

Title
Andrew Bowdle MD, PhD, FASE
Organization
University of Washington

Study Officials

  • T. Andrew Bowdle, MD, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, School of Medicine

Study Record Dates

First Submitted

August 10, 2021

First Posted

August 16, 2021

Study Start

February 1, 2022

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

July 8, 2026

Results First Posted

July 8, 2026

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations